Regenerative Medical Technology Group Inc.

Definitive information statement

Other Events

General form for quarterly reports under Section 13 or 15(d)

No description available

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Notice of Effectiveness

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Results of Operations and Financial Condition

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

Results of Operations and Financial Condition

Notification of late filing of Form 10-Q

8.01

Notice of Effectiveness

Post-effective amendment to a registration statement

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Definitive information statement

No description available

No description available

Notice of Effectiveness

Letter from the SEC

Correspondence with the SEC

Registration (IPO) statement under Securities Act of 1933

1.01,3.02,9.01

4.01,9.01

Entry into a Material Definitive Agreement

4.01,9.01

1.01,2.01,3.02,5.01,5.02,8.01,9.01

1.01,3.02,3.03,5.02,5.03,7.01,9.01

1.01,3.03,9.01

Entry into a Material Definitive Agreement

5.01,5.02

8.01

1.01,3.03,9.01

8.01

1.01,3.03,9.01

1.01,3.02,3.03,5.02,5.03,7.01,9.01

8.01,9.01

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

No description available

Novas Benito

Christensen David Eugene

Christensen David Eugene

Pereira Melvin Antonio Loria